Journal of Computer Science and Technology ›› 2021, Vol. 36 ›› Issue (2): 276-287.doi: 10.1007/s11390-021-0740-2
Special Issue: Emerging Areas
• Special Section on AI and Big Data Analytics in Biology and Medicine • Previous Articles Next Articles
Ling-Yun Dai, Member, CCF, Jin-Xing Liu*, Senior Member, CCF, Rong Zhu, Member, CCF, Juan Wang, Member, CCF, and Sha-Sha Yuan, Member, CCF
|  Akhtar M M, Micolucci L, Islam S M et al. Bioinformatic tools for microRNA dissection. Nucleic Acids Research, 2016, 44(1):24-44. DOI:10.1093/nar/gkv1221.
 Miska E A. How microRNAs control cell division, differentiation and death. Current Opinion in Genetics & Development, 2005, 15(5):563-568. DOI:10.1016/j.gde.2005.08.005.
 Cheng A M, Byrom M W, Shelton J et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Research, 2005, 33(4):1290-1297. DOI:10.1093/nar/gki200.
 Xu P, Guo M, Hay B A. MicroRNAs and the regulation of cell death. TRENDS in Genetics, 2004, 20(12):617-624. DOI:10.1016/j.tig.2004.09.010.
 Alshalalfa M, Alhajj R. Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures. BMC Bioinformatics, 2013, 14(Suppl 12):Article No. S1. DOI:10.1186/1471-2105-14-S12-S1.
 Fesler A, Zhai H, Ju J. miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer. OncoTargets and Therapy, 2004, 7:1481-1485. DOI:10.2147/OTT.S65548.
 Wu C, Li M, Hu C et al. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Molecular Biology Reports, 2014, 41(3):1257-1266. DOI:10.1007/s11033-013-2970-z.
 Xiong S W, Lin T X, Xu K W et al. MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer. Pathology Oncol. Res., 2013, 19(3):529-537. DOI:10.1007/s12253-013-9613-5.
 Zhao H, Zhang J, Shao H et al. miRNA-340 inhibits osteoclast differentiation via repression of MITF. Bioscience Reports, 2017, 37(4):Article No. BSR20170302. DOI:10.1042/BSR20170302.
 He F, Lv P, Zhao X et al. Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction. Molecular and Cellular Biochemistry, 2014, 394(1/2):137-144. DOI:10.1007/s11010-014-2089-0.
 Chen X, Xie D, Zhao Q et al. MicroRNAs and complex diseases:From experimental results to computational models. Briefings in Bioinformatics, 2019, 20(2):515-539. DOI:10.1093/bib/bbx130.
 Chen X, Sun L G, Zhao Y. NCMCMDA:MiRNA-disease association prediction through neighborhood constraint matrix completion. Briefings in Bioinformatics, 2021, 22(1):485-496. DOI:10.1093/bib/bbz159.
 Chen X, Zhu C C, Yin J. Ensemble of decision tree reveals potential miRNA-disease associations. PLoS Computational Biology, 2019, 15(7):Article No. e1007209. DOI:10.1371/journal.pcbi.1007209.
 Chen X, Huang L, Xie D, Zhao Q. EGBMMDA:Extreme gradient boosting machine for MiRNA-disease association prediction. Cell Death & Disease, 2018, 9(1):Article No. 3. DOI:10.1038/s41419-017-0003-x.
 Huang F, Yue X, Xiong Z K et al. Tensor decomposition with relational constraints for predicting multiple types of microRNA-disease associations. Briefings in Bioinformatics. DOI:10.1093/bib/bbaa140.
 Zhang W, Li Z S, Guo W Z et al. A fast linear neighborhood similarity-based network link inference method to predict microRNA-disease associations. IEEE/ACM Transactions on Computational Biology and Bioinformatics. DOI:10.1109/TCBB.2019.2931546.
 Chen M, Liao B, Li Z. Global similarity method based on a two-tier random walk for the prediction of microRNAdisease association. Scientific Reports, 2018, 8(1):Article No. 6481. DOI:10.1038/s41598-018-24532-7.
 Gao Y L, Cui Z, Liu J X et al. NPCMF:Nearest profilebased collaborative matrix factorization method for predicting miRNA-disease associations. BMC Bioinformatics, 2019, 20(1):Article No. 353. DOI:10.1186/s12859-019-2956-5.
 Yin M M, Cui Z, Gao Y L et al. LWPCMF:Logistic weighted profile-based collaborative matrix factorization for predicting MiRNA-disease associations. IEEE/ACM Transactions on Computational Biology and Bioinformatics. DOI:10.1109/TCBB.2019.2937774.
 Jiang Q, Hao Y, Wang G et al. Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Systems Biology, 2010, 4(Suppl 1):Article No. S2. DOI:10.1186/1752-0509-4-S1-S2.
 Xuan P, Han K, Guo M et al. Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors. PLoS ONE, 2013, 8(8):Article No. e70204. DOI:10.1371/journal.pone.0070204.
 Xuan P, Han K, Guo Y et al. Prediction of potential diseaseassociated microRNAs based on random walk. Bioinformatics, 2015, 31(11):1805-1815. DOI:10.1093/bioinformatics/btv039.
 Chen X, Liu M X, Yan G Y. RWRMDA:Predicting novel human microRNA-disease associations. Molecular BioSystems, 2012, 8(10):2792-2798. DOI:10.1039/c2mb25180a.
 Mørk S, Pletscher-Frankild S, Palleja A et al. Protein-driven inference of miRNA-disease associations. Bioinformatics, 2014, 30(3):392-397. DOI:10.1093/bioinformatics/btt677.
 Shi H B, Xu J, Zhang G D et al. Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes. BMC Systems Biology, 2013, 7(1):Article No. 101. DOI:10.1186/1752-0509-7-101.
 Chen X, Niu Y W, Wang G H, Yan G Y. MKR-MDA:Multiple kernel learning-based Kronecker regularized least squares for MiRNA-disease association prediction. Journal of Translational Medicine, 2017, 15(1):Article No. 251. DOI:10.1186/s12967-017-1340-3.
 Chen X, Yan C C, Zhang X et al. WBSMDA:Within and between score for MiRNA-disease association prediction. Scientific Reports, 2016, 6(1):Article No. 21106. DOI:10.1038/srep21106.
 You Z, Huang Z A, Zhu Z X et al. PBMDA:A novel and effective path-based computational model for miRNAdisease association prediction. PLoS Computational Biology, 2017, 13(3):Article No. e1005455. DOI:10.1371/journal.pcbi.1005455.
 Claude P, Gardès J. Prediction of miRNA-disease associations with a vector space mode. Scientific Reports, 2016, 6(1):Article No. 27036. DOI:10.1038/srep27036.
 Chen X, Huang L. LRSSLMDA:Laplacian regularized sparse subspace learning for MiRNA-disease association prediction. PLoS Computational Biology, 2017, 13(12):Article No. e1005912. DOI:10.1371/journal.pcbi.1005912.
 Luo J, Xiao Q. A novel approach for predicting microRNAdisease associations by unbalanced bi-random walk on heterogeneous network. Journal of Biomedical Informatics, 2017, 66:194-203. DOI:10.1016/j.jbi.2017.01.008.
 Chen X, Xie D, Wang L et al. BNPMDA:Bipartite network projection for MiRNA-disease association prediction. Bioinformatics, 2018, 34(18):3178-3186. DOI:10.1093/bioinformatics/bty333.
 Chen X, Wang L, Qu J, Guan N N, Li J Q. Predicting miRNA-disease association based on inductive matrix completion. Bioinformatics, 2018, 34(24):4256-4265. DOI:10.1093/bioinformatics/bty503.
 Chen X, Yin J, Qu J, Huang L. MDHGI:Matrix decomposition and heterogeneous graph inference for miRNAdisease association prediction. PLoS Computational Biology, 2018, 14(8):Article No. e1006418. DOI:10.1371/journal.pcbi.1006418.
 Zhao Y, Chen X, Yin J. Adaptive boosting-based computational model for predicting potential miRNA-disease associations. Bioinformatics, 2019, 35(22):4730-4738. DOI:10.1093/bioinformatics/btz297.
 Wang L, You Z H, Chen X et al. LMTRDA:Using logistic model tree to predict MiRNA-disease associations by fusing multi-source information of sequences and similarities. PLoS Computational Biology, 2019, 15(3):Article No. e1006865. DOI:10.1371/journal.pcbi.1006865.
 Ezzat A, Zhao P, Wu M et al. Drug-target interaction prediction with graph regularized matrix factorization. IEEE/ACM Transactions on Computational Biology & Bioinformatics, 2017, 14(3):646-656. DOI:10.1109/TCBB.2016.2530062.
 Yan C, Duan G H, Wu F X et al. BRWMDA:Predicting microbe-disease associations based on similarities and birandom walk on disease and microbe networks. IEEE/ACM Transactions on Computational Biology & Bioinformatics, 2020, 17(5):1595-1604. DOI:10.1109/TCBB.2019.2907626.
 Chen X, Yan G Y. Semi-supervised learning for potential human microRNA-disease associations inference. Scientific Reports, 2014, 4(1):Article No. 5501. DOI:10.1038/srep05501.
 Sun Q, Zhao X, Liu X et al. miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1. The Prostate, 2014, 74(16):1613-1621. DOI:10.1002/pros.22878.
 Wang B S, Liu Z, Xu W X et al. Functional polymorphisms in microRNAs and susceptibility to liver cancer:A meta-analysis and meta-regression. Genetics and Molecular Research, 2014, 13(3):5426-5440. DOI:10.4238/2014.July.24.22.
 Guo H, Liu H, Mitchelson K et al. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology, 2011, 54(3):808-819. DOI:10.1002/hep.24441.
 Shi W, Zhang Z, Yang B et al. Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma. Medicine, 2017, 96(32):Article No. e7764. DOI:10.1097/MD.0000000000007764.
 Karakatsanis A, Papaconstantinou I, Gazouli M et al. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangioca rcinoma and its prognostic significance. Molecular Carcinogenesis, 2013, 52(4):297-303. DOI:10.1002/MC.21864.
 Kwanhian W, Lenze D, Alles J et al. MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Medicine, 2012, 1(2):141-155. DOI:10.1002/cam4.29.
|No related articles found!|